Effect of different durations and formulations of diltiazem on the single-dose pharmacokinetics of midazolam: how long do we go? (Q39796487)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21209240%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Effect of different durations and formulations of diltiazem on the single-dose pharmacokinetics of midazolam: how long do we go? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21209240%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21209240%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Evan J Friedman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21209240%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Iain P Fraser

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21209240%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Ying-Hong Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21209240%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Arthur J Bergman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21209240%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Patrick J Larson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21209240%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Jeffrey Chodakewitz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21209240%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

John A Wagner

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21209240%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

S Aubrey Stoch

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21209240%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

1 reference

5 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21209240%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Clinical Pharmacology

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21209240%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21209240%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21209240%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

1561-1570

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21209240%20AND%20SRC:MED&resulttype=core&format=json

Pharmacokinetic interaction between single oral doses of diltiazem and sirolimus in healthy volunteers

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270010387141

Dose of midazolam should be reduced during diltiazem and verapamil treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010387141

Effect of different durations of ketoconazole dosing on the single-dose pharmacokinetics of midazolam: shortening the paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010387141

The Simcyp population-based ADME simulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010387141

Confidence assessment of the Simcyp time-based approach and a static mathematical model in predicting clinical drug-drug interactions for mechanism-based CYP3A inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010387141

Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010387141

The Conduct of In Vitro and In Vivo Drug-Drug Interaction Studies: A PhRMA Perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010387141

Drug-metabolizing enzyme inhibition by ketoconazole does not reduce interindividual variability of CYP3A activity as measured by oral midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010387141

Mechanism-based inactivation of human cytochrome P450 enzymes: strategies for diagnosis and drug-drug interaction risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010387141

Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010387141

In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010387141

The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010387141

Cytochrome p450 turnover: regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010387141

21 January 2018

Identifiers

DOI

10.1177/0091270010387141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21209240%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference